Champlain Investment Partners, LLC Procept Bio Robotics Corp Transaction History
Champlain Investment Partners, LLC
- $13.5 Billion
- Q2 2025
A detailed history of Champlain Investment Partners, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Champlain Investment Partners, LLC holds 1,070,646 shares of PRCT stock, worth $41.3 Million. This represents 0.46% of its overall portfolio holdings.
Number of Shares
1,070,646
Previous 676,196
58.33%
Holding current value
$41.3 Million
Previous $39.4 Million
56.54%
% of portfolio
0.46%
Previous 0.3%
Shares
8 transactions
Others Institutions Holding PRCT
# of Institutions
292Shares Held
44MCall Options Held
248KPut Options Held
90.9K-
Vanguard Group Inc Valley Forge, PA5.25MShares$203 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$135 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.16MShares$83.3 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.53MShares$59 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.32MShares$51 Million0.01% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $1.72B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...